Heavy metals, organic solvents, and multiple sclerosis: An exploratory look at gene-environment interactions

References

• Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004;3:709–718.
   PubMed Web of Science ®Google Scholar
• Weiner HL. A 21 point unifying hypothesis on the etiology and treatment of multiple sclerosis. Can J Neurol Sci. 1998;25:93–101.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 2010;9:599–612.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol. 2007;61:504–513.
   PubMed Web of Science ®Google Scholar
• Irvine DG, Schiefer HB, Hader WJ. Geotoxicology of multiple sclerosis: the Henribourg, Saskatchewan, cluster focus. II. The soil. Sci Total Environ. 1988;77:175–188.
   PubMed Web of Science ®Google Scholar
• Lauer K, Firnhaber W. Epidemiological investigations into multiple sclerosis in Southern Hesse. III. The possible influence of occupation on the risk of disease. Acta Neurol Scand. 1985;72:397–402.
   PubMed Web of Science ®Google Scholar
• Aminzadeh KK, Etminan M. Dental amalgam and multiple sclerosis: a systematic review and meta-analysis. J Public Health Dent. 2007;67:64–66.
   PubMed Web of Science ®Google Scholar
• Landtblom AM, Flodin U, Söderfeldt B, Wolfson C, Axelson O. Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology. 1996;7:429–433.
   PubMed Web of Science ®Google Scholar
• Moszczynski P. Organic solvents and T lymphocytes [Letter to the editor]. Lancet. 1981;317:438.
   Google Scholar
• Riise T, Kirkeleit J, Aarseth JH, et al. Risk of MS is not associated with exposure to crude oil, but increases with low level of education. Mult Scler. 2011;17:780–787.
   PubMed Web of Science ®Google Scholar
• El-Fawal HA, Waterman SJ, De Feo A, Shamy MY. Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms. Environ Health Perspect. 1999;107(Suppl 5):767–775.
   PubMed Web of Science ®Google Scholar
• Stejskal J, Stejskal VD. The role of metals in autoimmunity and the link to neuroendocrinology. Neuro Endocrinol Lett. 1999;20:351–364.
   PubMedGoogle Scholar
• Hansson M, Djerbi M, Rabbani H, et al. Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice. Immunology. 2005;114:428–437.
   PubMed Web of Science ®Google Scholar
• Callaghan B, Feldman D, Gruis K, Feldman E. The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications. Neurodegener Dis. 2011;8:1–8.
   PubMed Web of Science ®Google Scholar
• Dietert RR, Piepenbrink MS. Lead and immune function. Crit Rev Toxicol. 2006;36:359–385.
   PubMed Web of Science ®Google Scholar
• Via CS, Nguyen P, Niculescu F, Papadimitriou J, Hoover D, Silbergeld EK. Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect. 2003;111:1273–1277.
   PubMed Web of Science ®Google Scholar
• Barragán-Martínez C, Speck-Hernández CA, Montoya-Ortiz G, Mantilla RD, Anaya JM, Rojas-Villarraga A. Organic solvents as risk factor for autoimmune diseases: A systematic review and meta-analysis. PLoS ONE. 2012;7:e51506.
   PubMed Web of Science ®Google Scholar
• Leira HL, Fonnum F, Syversen T. Organic solvents. In: Ballantyne B, Marrs TC, Syversen T, eds. General and Applied Toxicology. Chichester, UK: John Wiley & Sons; 2009.
   Google Scholar
• Kenealy SJ, Pericak-Vance MA, Haines JL. The genetic epidemiology of multiple sclerosis. J Neuroimmunol. 2003;143:7–12.
   PubMed Web of Science ®Google Scholar
• Hawkes CH, Macgregor AJ. Twin studies and the heritability of MS: a conclusion. Mult Scler. 2009;15:661–667.
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357:851–862.
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009;5:e1000369.
   PubMed Web of Science ®Google Scholar
• Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 1990;346:183–187.
   PubMed Web of Science ®Google Scholar
• Montgomery SL, Bowers WJ. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol. 2012;7:42–59.
   PubMed Web of Science ®Google Scholar
• Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol. 2004;3:104–110.
   PubMed Web of Science ®Google Scholar
• Landtblom AM, Wastenson M, Ahmadi A, Söderkvist P. Multiple sclerosis and exposure to organic solvents, investigated by genetic polymorphisms of the GSTM1 and CYP2D6 enzyme systems. Neurol Sci. 2003;24:248–251.
   PubMed Web of Science ®Google Scholar
• Williamson DM, Marrie RA, Ashley-Koch A, Schiffer R, Trottier J, Wagner L. Design, methodological issues and participation in a multiple sclerosis case-control study. Acta Neurol Scand. 2012;126:197–204.
   PubMed Web of Science ®Google Scholar
• Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227–231.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–127.
   PubMed Web of Science ®Google Scholar
• Sadovnick AD, Dyment D, Ebers GC. Genetic epidemiology of multiple sclerosis. Epidemiol Rev. 1997;19:99–106.
   PubMed Web of Science ®Google Scholar
• Willer CJ, Ebers GC. Susceptibility to multiple sclerosis: interplay between genes and environment. Curr Opin Neurol. 2000;13:241–247.
   PubMed Web of Science ®Google Scholar
• Meng Z, Zaykin DV, Xu CF, Wagner M, Ehm MG. Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. Am J Hum Genet. 2003;73:115–130.
   PubMed Web of Science ®Google Scholar
• Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004;74:106–120.
   PubMed Web of Science ®Google Scholar
• Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–575.
   PubMed Web of Science ®Google Scholar
• Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452–456.
   PubMed Web of Science ®Google Scholar
• Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 2006;52:61–76.
   PubMed Web of Science ®Google Scholar
• Ingalls TH. Endemic clustering of multiple sclerosis in time and place, 1934–1984. Confirmation of a hypothesis. Am J Forensic Med Pathol. 1986;7:3–8.
   PubMed Web of Science ®Google Scholar
• Visconti A, Cotichini R, Cannoni S, et al. Concentration of elements in serum of patients affected by multiple sclerosis with first demyelinating episode: a six-month longitudinal follow-up study. Ann Ist Super Sanita. 2005;41:217–222.
   PubMedGoogle Scholar
• O'Gorman C, Lucas R, Taylor B. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci. 2012;13:11718–11752.
   PubMed Web of Science ®Google Scholar
• Lill CM, Liu T, Schjeide BM, et al. Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. J Med Genet. 2012;49:558–562.
   PubMed Web of Science ®Google Scholar
• Xuan C, Zhang BB, Li M, Deng KF, Yang T, Zhang XE. No association between APOE ϵ 4 allele and multiple sclerosis susceptibility: a meta-analysis from 5472 cases and 4727 controls. J Neurol Sci. 2011;308:110–116.
   PubMed Web of Science ®Google Scholar
• Montgomery SL, Bowers WJ. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol. 2012;7:42–59.
   PubMed Web of Science ®Google Scholar
• Mycko M, Kowalski W, Kwinkowski M, et al. Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha. J Neuroimmunol. 1998;84:198–206.
   PubMed Web of Science ®Google Scholar
• Fernandes Filho JAM, Vedeler CA, Myhr K-M, Nyland H, Pandey JP. TNF-α and -β gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-β gene. Autoimmunity. 2002;35:377–380.
   PubMed Web of Science ®Google Scholar
• Anaya JM. The autoimmune tautology. Arthritis Res Ther. 2010;12:147.
   PubMed Web of Science ®Google Scholar
• Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV. Smoking and multiple sclerosis: an updated meta-analysis. PLoS ONE. 2011;6:e16149.
   PubMed Web of Science ®Google Scholar
• Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462–1471.
   PubMed Web of Science ®Google Scholar
• Källberg H, Ding B, Padyukov L, et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011;70:508–511.
   PubMed Web of Science ®Google Scholar
• Cotsapas C, Voight BF, Rossin E, et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 2011;7:e1002254.
   PubMed Web of Science ®Google Scholar
• Miller FW, Pollard KM, Parks CG, et al. Criteria for environmentally associated autoimmune diseases. J Autoimmun. 2012;39:253–258.
   PubMed Web of Science ®Google Scholar
• Teschke K, Olshan AF, Daniels JL, et al. Occupational exposure assessment in case-control studies: opportunities for improvement. Occup Environ Med. 2002;59:575–593; discussion 594.
   PubMed Web of Science ®Google Scholar
• Stewart PA, Stewart WF, Siemiatycki J, Heineman EF, Dosemeci M. Questionnaires for collecting detailed occupational information for community-based case control studies. Am Ind Hyg Assoc J. 1998;59:39–44.
   PubMed Web of Science ®Google Scholar
• Daniels JL, Olshan AF, Teschke K, Hertz-Picciotto I, Savitz DA, Blatt J. Comparison of assessment methods for pesticide exposure in a case-control interview study. Am J Epidemiol. 2001;153:1227–1232.
   PubMed Web of Science ®Google Scholar
• Nieuwenhuijsen MJ. Design of exposure questionnaires for epidemiological studies. Occup Environ Med. 2005;62:272–280, 212–214.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Simpson S, Holloway AF, Charlesworth J, van der Mei I, Taylor BV. The potential role of epigenetic modifications in the heritability of multiple sclerosis. Mult Scler. 2014;20:135–140.
   PubMed Web of Science ®Google Scholar
• Taylor BV. The major cause of multiple sclerosis is environmental: genetics has a minor role—yes. Mult Scler. 2011;17:1171–1173.
   PubMed Web of Science ®Google Scholar
• Bender R, Lange S. Adjusting for multiple testingwhen and how? J Clin Epidemiol. 2001;54:343–349.
   PubMed Web of Science ®Google Scholar
• Westfall PH, Zaykin DV, Young SS. Multiple tests for genetic effects in association studies. In: Looney SW, ed. Biostatistical Methods. Vol 184. Totowas, NJ: Humana Press; 2002:143–168.
   Google Scholar
• Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43–46.
   PubMedGoogle Scholar
• Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol. 1995;142:904–908.
   PubMed Web of Science ®Google Scholar
• Poole C. Multiple comparisons? No problem! Epidemiology. 1991;2:241–243.
   PubMedGoogle Scholar
• Gelman A, Hill J, Yajima M. Why we (usually) don't have to worry about multiple comparisons. J Res Educ Effect. 2012;5:189–211.
   Web of Science ®Google Scholar